Our results let conclude that DC‐2 treatment in HeLa cells and SW480 colon carcinoma cells might have impacted the localization and functionality of different palmitoylation substrates like HRas and ERK1/2, and likely sensitized EGFR to epidermal growth factor (EGF) stimulation. The gene discussed is EGF; the disease is colon carcinoma.